AIDS conference coverage online
Once again, the Kaiser Family Foundation is offering extensive coverage of the XVIII International AIDS Conference in Vienna, Austria.
Today’s program features sessions about people with HIV and tuberculosis; prevention of mother-to-child transmission; HIV testing; the role of families in prevention, treatment and care; policies and measure ins Europe and more.
The Foundation is offering webcasts of sessions and interviews with newsmakers, as well as daily observations from Science magazine reporter Jon Cohen.
The conference website include slides, audio synched to the slides, rapporteur reports, links to abstracts and webcasts.
In related news, health journalists have been discussing an embargo break on a study that was presented at the conference. AHCJ board member and Reuters Health Editor Ivan Oransky has covered the situation here and here on his Embargo Watch blog.
U.S. global health policy focus of guide
In recognition of the major role global health issues now play in even the most local stories, the Kaiser Family Foundation has released a 41-page “Reporter’s Guide to U.S. Global Health Policy” (PDF).
The guide devotes sections to diseases/issues (HIV/AIDS, Malaria, Tuberculosis, Neglected Tropical Diseases, Maternal and Child Health, Water-Related Diseases, Food Insecurity), U.S. funding of global health efforts (Obama’s Global Health Initiative), relevant policy issues and policymaking. It also catalogues and explains related multinational and NGO efforts and lists news-making events.
AIDS advocates: Obama needs to use leverage
Filed under: Government, Health care reform, Health policy, Hot Health Headline, Pharmaceuticals, Public health
The Chicago Tribune’s Tom Hamburger reports that several global health advocacy organizations, including Doctors without Borders and OxFam International, have criticized the Obama administration for not helping to remove Bush-era impediments (primarily regarding pharmaceutical patent enforcement) to cheaper drugs overseas. Advocates claim officials are unwilling to confront major pharmaceutical companies at a time when their cooperation is needed in negotiations surrounding health care reform. For their part, administration officials point out that language in their reports has softened somewhat from that of the previous administration.


